Research Topics
Species | Michael E FarkouhSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Clinical risk stratification in the emergency department predicts long-term cardiovascular outcomes in a population-based cohort presenting with acute chest pain: primary results of the Olmsted county chest pain studyMichael E Farkouh
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA
Medicine (Baltimore) 88:307-13. 2009..This algorithm, when applied in the ED, affords an excellent opportunity to identify patients who might benefit from a more aggressive cardiovascular risk factor management strategy...
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular eventsVenkatesh Mani
Imaging Science Laboratories Translational and Molecular Imaging Institute, Department of Radiology, Mount Sinai School of Medicine, New York, NY, USA
J Cardiovasc Magn Reson 11:10. 2009..The purpose of this study was to determine if patients with traditional risk factors and prior MACE had increased cardiovascular magnetic resonance (CMR) plaque burden measures compared to patients with risk factors but no prior events...
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibM E Farkouh
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1074, New York, NY 10029, USA
Ann Rheum Dis 66:764-70. 2007..However, evidence from prospective studies of currently available COX-2 inhibitors and non-selective NSAIDs is lacking in patients at high cardiovascular risk who are taking aspirin...
CRP has little incremental value over traditional cardiovascular risk factors in risk stratificationMichael E Farkouh
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Nat Clin Pract Cardiovasc Med 4:290-1. 2007
Risk profiling patients for selective use of drug-eluting stents is warrantedMichael E Farkouh
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029 USA
Nat Clin Pract Cardiovasc Med 4:346-7. 2007
A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxenMichael E Farkouh
Clinical Trials Unit, Mount Sinai Cardiovascular Institute, New York, NY 10029, USA
J Clin Hypertens (Greenwich) 10:592-602. 2008..0001) and +0.43 with lumiracoxib compared with +1.80 mm Hg with naproxen (P<.0001). In conclusion, the use of lumiracoxib and traditional NSAIDs results in differing BP changes; these might be of clinical relevance...
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) TrialMichael E Farkouh
Mount Sinai School of Medicine, New York, NY 10029, USA
Am Heart J 155:215-23. 2008..The FREEDOM Trial is designed to determine whether CABG or percutaneous coronary intervention (PCI) is the superior approach for revascularization of diabetic patients...
Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectorisMichael E Farkouh
Mount Sinai School of Medicine, Cardiovascular Institute, New York, New York, USA
Am J Cardiol 104:492-7. 2009..DM should be included as a high-risk variable in national acute coronary syndrome guidelines...
An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarctionMichael E Farkouh
Cardiovascular Institute, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, New York 10029, USA
Clin Cardiol 29:204-10. 2006..The role of diabetes mellitus (DM) in cardiogenic shock (CS) complicating an acute myocardial infarction (AMI) is not well understood. Previous studies have reported an in-hospital mortality rate for patients with DM and CS of about 60%...
An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugsMichael E Farkouh
Mount Sinai Heart Clinical Trials Unit, Mount Sinai School of Medicine, New York, New York, USA
Am J Cardiol 103:1227-37. 2009....
Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptakeJan Bucerius
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
J Am Coll Cardiol 59:2080-8. 2012..In this study, the impact of noninsulin-dependent type 2 diabetes mellitus on carotid wall (18)F-fluorodeoxyglucose (FDG) uptake in patients with documented or suspected cardiovascular disease was evaluated...
Aspirin use is associated with an improved long-term survival in an unselected population presenting with unstable anginaLouai Razzouk
Division of Cardiology Department of Medicine, NYU Langone Medical Center, New York, NY, USA
Clin Cardiol 33:553-8. 2010..Few published data are available on the benefits of aspirin use in patients with unstable angina (UA)...
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialZahi A Fayad
Translational and Molecular Imaging Institute and Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA
Lancet 378:1547-59. 2011..dal-PLAQUE is the first multicentre study using novel non-invasive multimodality imaging to assess structural and inflammatory indices of atherosclerosis as primary endpoints...
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trialMichael E Farkouh
Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
Lancet 364:675-84. 2004....
Biomarkers after risk stratification in acute chest pain (from the BRIC Study)Shiny Mathewkutty
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
Am J Cardiol 111:493-8. 2013..There is potential for their use in the early discharge of low-risk patients after clinical risk stratification...
Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging studyJan Bucerius
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
JACC Cardiovasc Imaging 4:1195-205. 2011..We investigated the prevalence and clinical risk factors of carotid vessel wall inflammation by means of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in a population consisting of coronary artery disease (CAD) patients...
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 148:764-75. 2004..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO VHarmony R Reynolds
Cardiovascular Clinical Research Center, New York University School of Medicine, New York, USA
Arch Intern Med 167:2054-60. 2007..Use of diagnostic and therapeutic modalities may also differ. There is controversy regarding whether female sex is an independent risk factor for death and/or bleeding...
C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary interventionLouai Razzouk
Cardiac Catheterization Laboratory and Clinical Trials Unit, Cardiovascular Institute, Mount Sinai Heart, New York, NY, USA
Am Heart J 158:277-83. 2009..Few data are available on the association of high-sensitivity C-reactive protein (hs-CRP) and mortality independent of low-density lipoprotein (LDL) cholesterol in patients undergoing percutaneous coronary intervention (PCI)...
Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain: CHEER substudyGautam Ramakrishna
Department of Internal Medicine and Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 80:322-9. 2005..Patients not suitable for ETT are likely to have abnormal stress imaging results. They represent a higher-risk cohort that could be routinely admitted to the hospital without reducing the effectiveness of the CPU strategy...
Causes of death and re-hospitalization in cardiogenic shockRaban V Jeger
Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
Acute Card Care 9:25-33. 2007..In cardiogenic shock, causes of death usually are cardiac. However, a systemic inflammatory response syndrome may influence outcome...
Long-term cardiovascular outcomes in patients with angina pectoris presenting with bundle branch blockSameer Bansilal
Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
Am J Cardiol 107:1565-70. 2011..In conclusion, appearance of LBBB or RBBB in patients presenting with angina predicts adverse long-term cardiovascular outcomes compared to patients without BBB...
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomographyZahi A Fayad
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Am Heart J 162:214-221.e2. 2011..Results are expected in 2011...
The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study entrySameer Bansilal
Mount Sinai School of Medicine, New York, NY
Am Heart J 164:591-9. 2012....
Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysisUsman Baber
Cardiac Catheterization Laboratory, Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA
Am J Cardiol 103:1513-7. 2009..67 (95% CI 1.52 to 8.86), respectively, for patients on dialysis. In conclusion, the TIMI risk score for UAP/non-ST elevation myocardial infarction discriminates mortality risk across the full range of CKD, including patients on dialysis...
The incremental value of troponin-I testing in patients with intermediate risk unstable anginaEvan Appelbaum
Cardiovascular Institute, Mount Sinai School of Medicine, New York, USA
Clin Cardiol 27:646-51. 2004..High troponin-I adds significant (p < 0.001) prognostic value in the patients at AHCPR intermediate risk and should be evaluated further in larger trials of such patients...
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh
Mount Sinai School of Medicine, New York, NY 10029, USA
N Engl J Med 367:2375-84. 2012..We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease...
Outcomes in patients with chest pain evaluated in a chest pain unit: the chest pain evaluation in the emergency room study cohortMichael W Cullen
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Am Heart J 161:871-7. 2011..Limited data exist on the long-term outcomes of patients who undergo evaluation in a chest pain unit (CPU)...
Is measuring C-reactive protein useful for guiding treatment in women > or = 60 years and men > or = 50 years of age?Paul Muntner
Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA
Am J Cardiol 104:354-8. 2009..Given the demonstrated benefits of statin therapy, cost of measuring CRP, and large percentage of older US adults with high CRP, universal statin therapy for older US adults warrants investigation...
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dlAnnapoorna S Kini
Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, New York, NY, USA
Am J Cardiol 103:350-4. 2009..58 to 0.79). In conclusion, in patients with LDL cholesterol levels <70 mg/dl who underwent percutaneous coronary intervention, a strong inverse association was present between HDL cholesterol level and all-cause mortality...
Periprocedural myocardial enzyme elevation: prognostic implications for current practiceSanjum S Sethi
Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Curr Cardiol Rep 14:424-32. 2012..In this review, we highlight significant concepts in the diagnosis, prognosis, and clinical impact of periprocedural myocardial enzyme elevation...
Optimal treatment of the diabetic patient with multivessel diseaseSameer Bansilal
Zena and Michael A Wiener Cardiovascular Institute, Marie Josee and Henry R Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, NY 10029, USA
Curr Cardiol Rep 10:272-84. 2008..In this article, we assess the evidence accumulated to date and discuss ongoing studies that will help better inform this intricate decision-making process...
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patientsM Urooj Zafar
Zena and Michael A Wiener, Cardiovascular Institute, New York, NY 10029, USA
Thromb Haemost 97:487-92. 2007..Plasma levels of ZK-807834 show a strong linear correlation with PT ratio. This direct factor-Xa inhibitor may reduce the need for additional potent glycoprotein IIbIIIa inhibition...
Elevated homocysteine levels in patients with end-stage renal diseaseAjith P Nair
Department of Internal Medicine, Mount Sinai School of Medicine, New York, NY, USA
Mt Sinai J Med 72:365-73. 2005..Further studies are needed to clarify the association between hyperhomocysteinemia and coronary risk in patients with ESRD...
Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary interventionSameer Bashey
The Mount Sinai Cardiovascular Institute, New York, New York, USA
Am J Cardiol 107:1415-20. 2011..In conclusion, BMI levels of 25.0 to 29.9 and 30 to 34.9 kg/m(2) were associated with lower all-cause mortality after PCI. However, an increased number of metabolic abnormalities translated into increased all-cause mortality...
Diabetes: making sense of the rosiglitazone controversyMichael E Farkouh
Clinical Trials Unit, Mount Sinai Cardiovascular Institute, One Gustave L Levy Place, Box 1074, New York, NY 10029, USA
Nat Rev Cardiol 7:366-7. 2010..A trial in which rosiglitazone and glipizide were compared supports earlier findings that rosiglitazone does not have an adverse effect on the progression of coronary atherosclerosis...
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PETClaudia Calcagno
FAHA, FACC, Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1234, New York, NY 10029, USA
Arterioscler Thromb Vasc Biol 28:1311-7. 2008..Our aim was to test 2 techniques, black blood dynamic contrast enhanced MRI (DCE-MRI) and 18-fluorine-fluorodeoxyglucose (18F-FDG) PET, to quantify inflammation expressed as plaque neovessels content in a rabbit model of atherosclerosis...
Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imagingVictoria Furer
Division of Rheumatology, New York University Hospital for Joint Diseases, New York, New York 10003, USA
Semin Arthritis Rheum 41:676-88. 2012....
Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tabletsM Urooj Zafar
Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
J Interv Cardiol 22:385-9. 2009..To compare the absorption of 300 mg clopidogrel administered crushed via nasogastric (NG) tube versus whole tablets taken orally in healthy volunteers...
Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiencyMichael A Rosenblum
Department of Internal Medicine, The Mount Sinai Medical Center, New York, N Y, USA
Nephron Clin Pract 113:c198-202. 2009..However, these benefits have not been reproduced in patients with severe renal disease (SRD). This study compared TLR rates in patients with severe renal insufficiency treated with DES vs. BMS...
Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probeAhmed Klink
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, Atran BM 24, Box 1234, One Gustave L Levy Place, New York, NY 10029, USA
Arterioscler Thromb Vasc Biol 30:403-10. 2010..We sought to determine whether the noninvasive in vivo visualization of activated platelets was effective when using a target-specific MRI contrast agent to identify thrombi, hallmarks of vulnerable or high-risk atherosclerotic plaques...
Variations in atherosclerosis and remodeling patterns in aorta and carotidsKatsumi Hayashi
Imaging Science Laboratories, Translational and Molecular Imaging Institute, Department of Radiology, Mount Sinai School of Med, New York, NY, USA
J Cardiovasc Magn Reson 12:10. 2010..The purpose of this study was to examine arterial remodeling and progression/regression of atherosclerosis in aorta and carotid arteries of individuals at risk for atherosclerosis normalized over a 1-year period...
Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trialMichael Kim
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Circ Cardiovasc Qual Outcomes 6:186-92. 2013..Same-day discharge after percutaneous coronary intervention (PCI) may be safe for some patients. Few data are available on patient-reported outcomes and preferences for same-day discharge after PCI...
Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trialsSanjum S Sethi
Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Curr Diab Rep 12:294-304. 2012....
Role of insulin resistance and hyperglycemia in the development of atherosclerosisSameer Bansilal
The Zena and Michael A Wiener Cardiovascular Institute and The Marie Josee and Henry R Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
Am J Cardiol 99:6B-14B. 2007..Efforts to prevent or slow the epidemic of atherothrombotic CVD must focus on the reversal of the disturbances in glucose and lipid homeostasis through the amelioration of IR...
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging studyJames H F Rudd
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, NY, USA
Circ Cardiovasc Imaging 2:107-15. 2009..We also tested the hypotheses that the degree of local arterial inflammation measured by PET is correlated with the extent of systemic inflammation and presence of risk factors for vascular disease...
Cardiovascular disease in diabetics: pharmacology and revascularizationSarang S Mangalmurti
Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
Mt Sinai J Med 71:375-83. 2004....
Prologue: relevance of molecular imaging in clinical medicineZahi A Fayad
Department of Radiology, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1030, New York, NY 10029, USA
Nat Clin Pract Cardiovasc Med 5:S1. 2008
Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future conceptsZahi A Fayad
Zena and Michael A. Wiener Cardiovascular Institute, New York, NY, USA
Circulation 106:2026-34. 2002
Atherothrombotic plaques and the need for imagingZahi A Fayad
Department of Radiology, Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Imaging Science Laboratories, Box 1234, New York, NY 10029, USA
Neuroimaging Clin N Am 12:351-64. 2002..The use of some of the available imaging modalities for the study of regression and progression of atherothrombosis are described in more detail in the subsequent articles...
Noncoronary and coronary atherothrombotic plaque imaging and monitoring of therapy by MRIZahi A Fayad
Department of Radiology, Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Imaging Science Laboratories, Box 1234, New York, NY 10029, USA
Neuroimaging Clin N Am 12:461-71. 2002..This may aid early intervention (e.g., lipid lowering drug regiments) in both primary and secondary treatment of vascular disease in all arterial beds...
Vascular MRI in the diagnosis and therapy of the high risk atherosclerotic plaqueJolanda J Wentzel
Zena and Michael A. Wiener Cardiovascular Institute, Imaging Science Laboratories, Mount Sinai School of Medicine, New York, NY, USA
J Interv Cardiol 16:129-42. 2003..It possibly will identify asymptomatic patients with subclinical atherosclerosis. This has potential significance for the improvement of strategies in primary and secondary prevention...
MR imaging for the noninvasive assessment of atherothrombotic plaquesZahi A Fayad
Department of Radiology, The Zena and Michael A Wiener Cardiovascular Institute, Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1234, New York, NY 10029, USA
Magn Reson Imaging Clin N Am 11:101-13. 2003..This may aid early intervention (eg, lipid-lowering drug regiments) in both primary and secondary treatment of vascular disease in all arterial beds...
Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesisClaudia Calcagno
Imaging Science Laboratories, Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1234, New York, NY 10029, USA
Angiogenesis 13:87-99. 2010..Finally, we will examine the current limitations and challenges faced by DCE-MRI and briefly discuss its future applications in the context of atherosclerosis...
High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosisTorjus Skajaa
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Arterioscler Thromb Vasc Biol 30:169-76. 2010..By rerouting of HDL away from plaque macrophages, imaging of biological processes in diseases besides atherosclerosis may also be achieved...
In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardiumEric D Adler
Cardiovascular Institute and Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
JACC Cardiovasc Imaging 2:1114-22. 2009....
Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaqueZahi A Fayad
Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1234, New York, NY 10029, USA
Curr Atheroscler Rep 6:232-42. 2004..MDCT and MRI, therefore, may help in selecting appropriate treatments...
Prenatal detection of embryo resorption in osteopontin-deficient mice using serial noninvasive magnetic resonance microscopyAndrea S Weintraub
The Mount Sinai School of Medicine, Box 1508, One Gustave L Levy Place, New York, NY 10029, USA
Pediatr Res 55:419-24. 2004..However, targeted disruption of one or more OPN alleles had no effect on embryo number at any gestational age. Thus, MRM may be a powerful noninvasive method for in vivo prenatal developmental study of genetically engineered mice...
Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approachEric Lancelot
Department of Radiology, The Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, Box 1234, One Gustave L Levy Place, New York, NY 10029, USA
Arterioscler Thromb Vasc Biol 28:425-32. 2008..This study evaluated the ability of the novel gadolinium-based MRI contrast agent P947 to target MMPs in atherosclerotic plaques...
Magnetic resonance imaging of coronary atherosclerosisZahi A Fayad
Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA
Curr Atheroscler Rep 5:411-7. 2003
Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRIJean Christophe Cornily
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029, USA
J Magn Reson Imaging 27:1406-11. 2008..To test whether B-22956/1, a novel intravascular contrast agent with a high affinity to serum albumin (Bracco Imaging SpA.), allowed quantifying neovessel and macrophage density in atherosclerotic plaques of rabbits using MRI...
The vulnerable plaque and acute coronary syndromesRoberto Corti
Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, New York, USA
Am J Med 113:668-80. 2002..These regimens focus on inhibiting thrombin, preventing thrombi generation, blocking the initiation of coagulation, inhibiting platelet activation, and increasing fibrinolysis...
Association between troponin I levels and mortality in stable hemodialysis patientsMichael E Farkouh
Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
Am J Med 114:224-6. 2003
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic optionsAshish Aneja
The Mount Sinai Cardiovascular Institute, New York, NY 10029, USA
Am J Med 121:748-57. 2008..Although glycemic control and early administration of neurohormonal antagonists remain the cornerstones of therapeutic approaches, newer treatment targets are currently being explored...
Imaging outcomes in cardiovascular clinical trialsLouai Razzouk
Mount Sinai Cardiovascular Institute, New York, NY 10029, USA
Nat Rev Cardiol 6:524-31. 2009..In the future, imaging modalities will be fundamental to research and drug development and an increased emphasis will be placed on the relationship between the results of imaging studies and clinical outcomes...
Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney diseasePaul Muntner
Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY, USA
Am J Cardiol 102:54-7. 2008..06 to 2.56) for myocardial infarction, angina, and stroke, respectively. In conclusion, a graded association exists between higher serum cystatin C and increased CVD prevalence in patients without established chronic kidney disease...
Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbitsClaudia Calcagno
Translational and Molecular Imaging Institute, Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029, USA
J Magn Reson Imaging 32:191-8. 2010....
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteriesStephane S Silvera
Sinai Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Atherosclerosis 207:139-43. 2009....
Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imagingJolanda J Wentzel
Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
J Am Coll Cardiol 45:846-54. 2005..The purpose of this study was to investigate the role of shear stress (SS) in plaque regression...
Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaquesJuan C Frias
Imaging Science Laboratories, Department of Radiology, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
J Am Chem Soc 126:16316-7. 2004..It also can distinguish between different types of plaques as the enhancement obtained is different, depending on plaque composition...
Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemiaEugene Trogan
Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
Arterioscler Thromb Vasc Biol 24:1714-9. 2004..Serial in vivo MRI will enhance studies of plaque regression in animal models in response to therapeutic interventions...
Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imagingMarc Sirol
, Mount Sinai School of Medicine, New York, NY 10029-6574, USA
Circulation 109:2890-6. 2004..CONCLUSIONS: Gadofluorine-enhanced MRI improves atherosclerotic plaque detection. The IR-DIFF-TFL method allows early detection of atherosclerotic plaque within 1 hour after gadofluorine injection...
Mouse model of heterotopic aortic arch transplantationIgor Chereshnev
Department of Medicine and the Zena and Michael Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Surg Res 111:171-6. 2003..Because lesion development is more rapid and exuberant in the aortic arch, a technique of transplantation of the mouse aortic arch was developed...
Parallel and nonparallel simultaneous multislice black-blood double inversion recovery techniques for vessel wall imagingVitalii V Itskovich
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
J Magn Reson Imaging 19:459-67. 2004..The DIR-RARE-GRAPPA multislice sequence showed 8.35-fold time improvement vs. single-slice DIR-2RARE sequence. CONCLUSION: Future MRI atherosclerotic plaque studies can be performed in substantially shorter times using these methods...
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trialsJames H F Rudd
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York, USA
J Am Coll Cardiol 50:892-6. 2007..This study tested the near-term reproducibility of (18)fluorodeoxyglucose positron emission tomography (FDG-PET) imaging of atherosclerosis...
A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosisStephen G Worthley
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
Arterioscler Thromb Vasc Biol 23:346-50. 2003..However, the resolution achievable using surface radiofrequency coils is limited by the signal to noise ratio. We studied the utility of a new intravascular (IV) MRI probe for high-resolution in vivo imaging of atherosclerotic lesions...
Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imagingRoberto Corti
Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, NY 10029, USA
Circulation 106:2884-7. 2002..Our observations indicate that lipid-lowering therapy is associated with sustained vascular remodeling and emphasize the need for longer-term treatment...
Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopyRobin P Choudhury
The Cardiovascular Institute, Mount Sinai School of Medicine, Box 1030, 1 Gustave L. Levy Place, New York, NY 10029-6574, USA
Atherosclerosis 162:315-21. 2002..0001) to be accommodated entirely by 'positive remodeling', confirming the importance of determining plaque size directly. MRM accurately quantifies mouse aortic atherosclerosis and will enhance studies in this important animal model...
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh
Mount Sinai School of Medicine, New York, New York Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada
J Am Coll Cardiol 61:1607-15. 2013....
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritisJeffrey D Greenberg
Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA
Ann Rheum Dis 70:576-82. 2011..To examine the association of cardiovascular events with tumour necrosis factor (TNF) α antagonist use compared with non-biological disease-modifying antirheumatic drug (DMARD) utilisation in patients with rheumatoid arthritis (RA)...
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomographyFabien Hyafil
Sinai Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, 1 Gustave L Levy Place, New York, New York 10029, USA
Nat Med 13:636-41. 2007..This contrast agent may become an important adjunct to the clinical evaluation of coronary arteries with CT...
Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imagingGerard Helft
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029 6574, USA
Circulation 105:993-8. 2002..Our aim was to monitor changes in burden and composition of atherosclerotic plaques in a rabbit model of complex atherosclerosis using serial noninvasive magnetic resonance imaging (MRI)...
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticlesDavid P Cormode
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Radiology 256:774-82. 2010....
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingRoberto Corti
Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, New York 10029, USA
J Am Coll Cardiol 46:106-12. 2005..No difference in vessel wall changes was seen between high and conventional doses of simvastatin. Changes in vessel wall parameters are more related to LDL-C reduction rather than to the dose of statin...
Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniquesVenkatesh Mani
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
J Magn Reson Imaging 22:628-33. 2005..CONCLUSION: Non-gated sequences may be used instead of gated sequences in atherosclerotic vessel wall imaging without compromising image quality. This may shorten examination time and improve patient comfort...
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendationsJames H F Rudd
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York, USA
J Nucl Med 49:871-8. 2008..We also reviewed the literature on quantification methods to determine the optimal measures of arterial 18F-FDG uptake for future studies...
Magnetic resonance microscopy quantifies the disease progression in Marfan syndrome miceVitalii V Itskovich
Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
J Magn Reson Imaging 17:435-9. 2003..05). CONCLUSION: MRM detected the differences in aortic size between WT and mutant mice over time, demonstrating a potential for noninvasive technique for the assessment of potential therapies in MFS mice...
Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histologyFabien Hyafil
Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029, USA
J Nucl Med 50:959-65. 2009..In this study, we tested whether the intensity of enhancement detected with CT in the aortic wall of rabbits injected with N1177 correlated with inflammatory activity evaluated with (18)F-FDG PET/CT and macrophage density on histology...
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosisMichael J Lipinski
Translational and Molecular Imaging Institute, Mount Sinai Medical Center, New York, New York, USA
JACC Cardiovasc Imaging 2:637-47. 2009..We sought to determine whether gadolinium (Gd)-containing lipid-based nanoparticles (NPs) targeting the macrophage scavenger receptor-B (CD36) improve cardiac magnetic resonance (CMR) detection and characterization of human atherosclerosis...
Imaging of atherosclerotic cardiovascular diseaseJavier Sanz
The Zena and Michael A Wiener Cardiovascular Institute and Marie Josee and Henry R Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, New York 10029, USA
Nature 451:953-7. 2008....
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosisStephen G Worthley
Zena and Michael A Wiener Cardiovascular Institute, The Mount Sinai Medical Center, New York, NY 10029, USA
Int J Cardiovasc Imaging 25:251-7. 2009..67 +/- 0.02 to 0.53 +/- 0.02, P < 0.0001). FDG PET can quantify in vivo macrophage content and serially monitor changes in FDG activity in this rabbit model...
Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aortaHamza El Aidi
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Nat Clin Pract Cardiovasc Med 6:219-28. 2009..We did a cross-sectional, prospective study to test reproducibility of MRI when imaging arteries, to assess risk of cardiovascular disease and correlations with age and sex...
Magnetic resonance molecular imaging contrast agents and their application in atherosclerosisWillem J M Mulder
Sinai Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, New York, NY 10029, USA
Top Magn Reson Imaging 18:409-17. 2007..Subsequent to the discussion of the above topics, we will describe some examples of molecular imaging agents that successfully detect specific markers in atherosclerotic plaques that are of interest in several stages of this disease...
Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imagingWillem J M Mulder
Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York 10029, USA
Acc Chem Res 42:904-14. 2009....
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopesKaren C Briley-Saebo
Imaging Science Laboratory, Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA
Circulation 117:3206-15. 2008....
COX-2 inhibitors and hypercoagulabilityMichael E Farkouh
New York University School of Medicine, New York, NY 10016, USA
Clin Adv Hematol Oncol 3:35-6. 2005
Cardiovascular safety of biologic therapies for the treatment of RAJeffrey D Greenberg
Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA jeffrey greenberg nyumc org
Nat Rev Rheumatol 8:13-21. 2012..Nevertheless, observational research using large registries has emerged as a promising approach to study the cardiovascular risk of emerging RA biologic therapies...
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgeryMichael J Domanski
Mount Sinai Cardiovascular Institute, New York, New York 10029, USA
JAMA 305:585-91. 2011..Also, the long-term prognostic impact of small increases of perioperative enzyme has not been reported...
Chagas disease as a mechanistic model for testing a novel hypothesisSerge A Mosovich
Department of Psychiatry, Mount Sinai School of Medicine, New York City, NY, USA
Rev Soc Bras Med Trop 41:70-2. 2008....
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosisStephen G Worthley
Cardiovascular Biology Research Laboratory, Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
Pathophysiol Haemost Thromb 36:9-17. 2007..007) and in combination with avasimibe (p = 0.04) versus controls. In this animal model, the addition of avasimibe to atorvastatin has beneficial effects on both atherosclerotic plaque regression and stabilization...
Research Grants
- Novel Imaging to Predict Cardiovascular Events in DiabetesZahi A Fayad; Fiscal Year: 2010..It is our expectation that our data will be utilized to evaluate and improve existent treatment and develop effective new therapies to decrease the burden of atherosclerotic disease in diabetes. ..
- Novel Imaging to Predict Cardiovascular Events in DiabetesMichael Farkouh; Fiscal Year: 2009..It is our expectation that our data will be utilized to evaluate and improve existent treatment and develop effective new therapies to decrease the burden of atherosclerotic disease in diabetes. ..
